We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
423
Increased
3,809
Reduced
3,216
Closed
305

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.02%
2 Technology 24.63%
3 Financials 9.78%
4 Healthcare 7.32%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STCE icon
6101
Schwab Crypto Thematic Natural Language Processing ETF
STCE
$241M
$99.5K ﹤0.01%
1,422
+1,421
+142,100% +$100K
PMN icon
6102
ProMIS Neurosciences
PMN
$125M
$99.5K ﹤0.01%
+7,559
New +$82.1K
CSHR
6103
CoinShares PLC
CSHR
$791M
$99.3K ﹤0.01%
+26,336
New +$139K
XDEC icon
6104
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$204M
$99.2K ﹤0.01%
2,316
NNNN
6105
Anbio Biotechnology
NNNN
$341M
$99.1K ﹤0.01%
7,231
-107
-1% -$2.68K
NYM
6106
AB New York Intermediate Municipal ETF
NYM
$1.3B
$99K ﹤0.01%
3,940
-9
-0.2% -$225
ACLC
6107
American Century Large Cap Equity ETF
ACLC
$325M
$98.7K ﹤0.01%
1,173
IGLD icon
6108
FT Vest Gold Strategy Target Income ETF
IGLD
$596M
$98.5K ﹤0.01%
4,678
+81
+2% +$1.93K
IMA
6109
ImageneBio Inc
IMA
$60.5M
$98.4K ﹤0.01%
16,678
-1,661
-9% -$9.38K
INSG icon
6110
Inseego
INSG
$72.3M
$98.1K ﹤0.01%
9,492
-17,549
-65% -$235K
PPTY
6111
US Diversified Real Estate ETF
PPTY
$25.3M
$98K ﹤0.01%
2,860
-250
-8% -$8.18K
TMFS icon
6112
Motley Fool Small-Cap Growth ETF
TMFS
$59M
$98K ﹤0.01%
2,711
-75
-3% -$2.57K
OFS icon
6113
OFS Capital
OFS
$49.4M
$97.6K ﹤0.01%
27,562
-12,001
-30% -$43.9K
HYTR icon
6114
CP High Yield Trend ETF
HYTR
$295M
$97.4K ﹤0.01%
4,559
+1,298
+40% +$27.8K
MLP icon
6115
Maui Land & Pineapple Co
MLP
$315M
$97.3K ﹤0.01%
5,471
-2,710
-33% -$44.9K
GDIV icon
6116
Harbor Dividend Growth Leaders ETF
GDIV
$240M
$97.1K ﹤0.01%
5,266
-223
-4% -$4.03K
OVL icon
6117
Overlay Shares Large Cap Equity ETF
OVL
$402M
$97.1K ﹤0.01%
1,715
-85
-5% -$4.74K
USD icon
6118
ProShares Ultra Semiconductors
USD
$2.78B
$96.1K ﹤0.01%
921
+475
+107% +$41.3K
MCRB icon
6119
Seres Therapeutics
MCRB
$49.7M
$95.8K ﹤0.01%
12,138
-9,562
-44% -$72.8K
EQ icon
6120
Equillium
EQ
$155M
$95.6K ﹤0.01%
29,887
+11,367
+61% +$27.2K
YLDE icon
6121
ClearBridge Dividend Strategy ESG ETF
YLDE
$173M
$95.2K ﹤0.01%
1,712
REVS icon
6122
Columbia Research Enhanced Value ETF
REVS
$347M
$94.9K ﹤0.01%
3,019
GSC icon
6123
Goldman Sachs Small Cap Equity ETF
GSC
$293M
$94.6K ﹤0.01%
1,366
-864
-39% -$53.2K
CNTN
6124
Canton Strategic Holdings
CNTN
$187M
$94.3K ﹤0.01%
33,449
+13,687
+69% +$43.3K
IPSC icon
6125
Century Therapeutics
IPSC
$404M
$94.2K ﹤0.01%
38,454
+12,205
+46% +$27.9K

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.